Feeds:
Posts
Comments

Archive for July 14th, 2010

Steven R. Gerbsman, Principal of Gerbsman Partners, Kenneth Hardesty and Dennis Sholl, members of Gerbsman Partners Board of Intellectual Capital, announced today their success in maximizing stakeholder value for a venture capital backed, medical device company company focused on a unique stent delivery platform that has applications in treating coronary, neuro and peripheral artery disease.

Gerbsman Partners provided Crisis Management and Investment Banking leadership, facilitated the sale of the business unit’s assets and its associated Intellectual Property. Due to market conditions, the board of directors made the strategic decision to maximize the value of the business unit and Intellectual Property.

Gerbsman Partners provided leadership to the company with:

  • Crisis Management and medical device domain expertise in developing the strategic action plans for maximizing value of the business unit, Intellectual Property and assets;
  • Proven domain expertise in maximizing the value of the business unit and Intellectual Property through a Gerbsman Partners targeted and proprietary “Date Certain M&A Process”;
  • The ability to “Manage the Process” among potential Acquirers, Lawyers, Creditors Management and Advisors;
  • The proven ability to “Drive” toward successful closure for all parties at interest.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 61 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $790 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, Alexandria, VA, San Francisco, Europe and Israel.

For additional information please visit www.gerbsmanpartners.com or
Gerbsman Partners blog.

Read Full Post »

Here is an article from SF Gate.

“The U.S. Department of Energy on Monday awarded $92 million in stimulus funds for research projects that could change the way the country uses and stores energy, with $22 million going to California companies and universities.

The money represents the Obama administration’s latest round of investments in green technology. The 2009 American Recovery and Reinvestment Act has already funded loans for several green Bay Area companies, such as Solyndra of Fremont and Tesla Motors of Palo Alto.

“By driving energy innovation, we can take the lead in high-tech energy manufacturing and export these products to the world,” said Energy Secretary Steven Chu.

Eleven projects in California received funding on Monday. Many focus on more energy-efficient cooling systems or better ways to store energy on a large scale – one of the clean tech industry’s holy grails.

Although most of the awards went to Southern California companies and labs, two Bay Area projects received funding. Lawrence Berkeley National Laboratory in Berkeley – which Chu used to run – won $1.6 million to develop flow batteries, a type of rechargeable battery in which reactive chemicals are pumped through the battery’s cells whenever energy is needed. And Primus Power of Alameda won $2 million to develop electrodes for flow batteries.”

Read more here.

Read Full Post »